Viyash Scientific Limited (NSE:VIYASH)
191.76
-1.17 (-0.61%)
Apr 2, 2026, 3:30 PM IST
Viyash Scientific Employees
Viyash Scientific had 1,244 employees as of March 31, 2025. The number of employees increased by 49 or 4.10% compared to the previous year.
Employees
1,244
Change (1Y)
49
Growth (1Y)
4.10%
Revenue / Employee
14.61M INR
Profits / Employee
784.47K INR
Market Cap
83.73B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,244 | 49 | 4.10% |
| Mar 31, 2024 | 1,195 | -106 | -8.15% |
| Mar 31, 2023 | 1,301 | -470 | -26.54% |
| Mar 31, 2022 | 1,771 | 1 | 0.06% |
| Mar 31, 2021 | 1,770 | 70 | 4.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 16,571 |
| Akums Drugs and Pharmaceuticals | 7,536 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Alivus Life Sciences | 2,203 |
| Aarti Pharmalabs | 2,162 |
| Cohance Lifesciences | 1,212 |
Viyash Scientific News
- 4 months ago - Sequent Scientific Ltd (BOM:512529) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 months ago - Q2 2026 SeQuent Scientific Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - SeQuent Scientific shares jump over 10% as NCLT approves merger with Viyash Lifesciences - Business Upturn
- 11 months ago - Sequent Scientific Q4 Results: Revenue up 11% YoY to Rs 401 crore - Business Upturn
- 1 year ago - Sequent Scientific Ltd (BOM:512529) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - GuruFocus
- 1 year ago - Sequent Scientific Q3 FY25 results: Revenue up 18.7% YoY to Rs 390.8 crore, Net profit declines 58.5% YoY - Business Upturn
- 1 year ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 1 year ago - SeQuent Scientific consolidates ownership of subsidiaries in Sweden and Italy - Business Upturn